Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) EBITDA Margin: 2009-2011

Historic EBITDA Margin for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -9,720.70%.

  • Lexicon Pharmaceuticals' EBITDA Margin fell 793099.00% to -9,720.70% in Q4 2011 from the same period last year, while for Dec 2011 it was -6,170.63%, marking a year-over-year decrease of 422039.00%. This contributed to the annual value of -6,170.63% for FY2011, which is 422039.00% down from last year.
  • As of Q4 2011, Lexicon Pharmaceuticals' EBITDA Margin stood at -9,720.70%, which was down 34.32% from -7,236.90% recorded in Q3 2011.
  • Over the past 5 years, Lexicon Pharmaceuticals' EBITDA Margin peaked at -565.50% during Q1 2009, and registered a low of -9,720.70% during Q4 2011.
  • Over the past 3 years, Lexicon Pharmaceuticals' median EBITDA Margin value was -1,952.47% (recorded in 2010), while the average stood at -3,385.01%.
  • Data for Lexicon Pharmaceuticals' EBITDA Margin shows a maximum YoY tumbled of 793,099bps (in 2011) over the last 5 years.
  • Lexicon Pharmaceuticals' EBITDA Margin (Quarterly) stood at -762.19% in 2009, then crashed by 102,751bps to -1,789.70% in 2010, then crashed by 793,099bps to -9,720.70% in 2011.
  • Its EBITDA Margin was -9,720.70% in Q4 2011, compared to -7,236.90% in Q3 2011 and -4,671.35% in Q2 2011.